Cite
Fouquet G, Hebraud B, Garciaz S, et al. Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation. J Cancer. 2014;5(3):248-52doi: 10.7150/jca.8541.
Fouquet, G., Hebraud, B., Garciaz, S., Stoppa, A. M., Roussel, M., Caillot, D., Chrétien, M. L., Arnulf, B., Szalat, R., Garderet, L., Benajiba, L., Pegourie, B., Regny, C., Royer, B., Caulier, A., Touzeau, C., Tessoulin, B., Fermand, J. P., Facon, T., Attal, M., Loiseau, H. A., Moreau, P., & Leleu, X. (2014). Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation. Journal of Cancer, 5(3), 248-52. https://doi.org/10.7150/jca.8541
Fouquet, Guillemette, et al. "Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation." Journal of Cancer vol. 5,3 (2014): 248-52. doi: https://doi.org/10.7150/jca.8541
Fouquet G, Hebraud B, Garciaz S, Stoppa AM, Roussel M, Caillot D, Chrétien ML, Arnulf B, Szalat R, Garderet L, Benajiba L, Pegourie B, Regny C, Royer B, Caulier A, Touzeau C, Tessoulin B, Fermand JP, Facon T, Attal M, Loiseau HA, Moreau P, Leleu X. Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation. J Cancer. 2014 Mar 11;5(3):248-52. doi: 10.7150/jca.8541. eCollection 2014. PMID: 24665349; PMCID: PMC3963082.
Copy
Download .nbib